Who Is Eligible for Weight-Loss Treatment?
Written by Sphere Pharmacy
12 August, 2026
Eligibility for weight-loss treatment depends on your BMI, weight-related health risks, previous lifestyle efforts and whether a treatment is safe for you. In the UK, prescription medication is usually considered after a clinical assessment and alongside sustainable changes to food, activity, sleep and behaviour.
What counts as weight-loss treatment?
Weight-loss treatment is broader than medication. It may include personalised nutrition support, physical activity planning, behavioural interventions, psychological support, structured weight-management programmes, prescription medication and, for a smaller group of people, bariatric surgery. The appropriate starting point depends on your health, preferences, goals and previous experience.
A clinician should take a weight-neutral, individual approach rather than focusing only on a number on the scales. Treatment may aim to improve blood pressure, blood glucose, mobility, sleep, energy or quality of life. Medication is one possible tool and does not replace nutritious eating, regular movement, adequate sleep or behavioural support.
Body mass index, or BMI, is calculated by dividing weight in kilograms by height in metres squared. For example, someone who weighs 90 kg and is 1.70 metres tall has a BMI of approximately 31.1. BMI is a screening measure rather than a diagnosis, so it should be interpreted alongside waist measurement, medical history and other risk factors.
Eligibility thresholds vary between medicines and services. In general, some prescription weight-loss medications may be considered for adults with a BMI of 30 kg/m² or above. They may also be considered from a BMI of 27 kg/m² when at least one weight-related condition is present, although the precise licensed criteria and NHS access rules differ by treatment.
Clinical guidance may recommend lower BMI thresholds for people from some ethnic backgrounds because metabolic risks can develop at a lower BMI. For example, assessment thresholds are commonly reduced by 2.5 kg/m² for adults from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds. A clinician should apply current guidance to the individual.
Meeting a BMI threshold does not automatically mean medication is suitable or available. Each treatment has its own authorised indication, cautions and monitoring requirements. NHS services may also use additional referral or prioritisation criteria, while regulated private providers must still complete an appropriate clinical assessment before prescribing.
Which health conditions can affect eligibility?
Weight-related conditions can influence whether treatment is clinically appropriate. These include high blood pressure, abnormal blood fats, prediabetes, type 2 diabetes, obstructive sleep apnoea and cardiovascular disease. Joint problems, fatty liver disease and polycystic ovary syndrome may also be relevant to the wider assessment, depending on the treatment and its licensed indication.
A clinician will consider how weight affects your current health and your likelihood of developing future complications. They should also check whether a medical condition or medicine could be contributing to weight change. An underactive thyroid, sleep disorder, mental health condition or certain medicines may need investigation or management as part of a safe plan.
The existence of a weight-related condition does not guarantee that a particular medicine can be prescribed. It may alter the balance of expected benefits and risks, but contraindications, interactions and practical factors still matter. Your clinician may request recent blood pressure readings, blood tests or information from your GP before reaching a decision.
What does a weight-loss treatment assessment involve?
A proper assessment usually records your height, weight, BMI and, where useful, waist circumference. The clinician should ask about weight history, eating patterns, physical activity, sleep, alcohol use, previous treatment attempts and the effect of weight on daily life. Honest information helps them identify an option that is both safe and realistic.
Your medical history is equally important. Expect questions about diabetes, heart disease, high blood pressure, digestive problems, pancreatitis, gallbladder disease, kidney or liver conditions, endocrine disorders and mental health. Depending on the proposed treatment, a personal or family history of certain cancers or other uncommon conditions may also be relevant.
The prescriber must review all medicines, supplements and allergies because interactions can change treatment safety. They will also ask about pregnancy, breastfeeding and plans to conceive. Prescription weight-loss medication is generally not used during pregnancy or breastfeeding, and some treatments need to be stopped for a specified period before a planned pregnancy.
A responsible service will verify key information where appropriate and explain expected benefits, common adverse effects, warning symptoms and follow-up arrangements. It should not prescribe solely from a BMI figure or a brief tick-box questionnaire. Photographic identification, recent measurements or access to relevant medical information may be requested to support safe prescribing.
Do you need to try diet and exercise before medication?
Prescription medication is normally considered as an addition to dietary, activity and behavioural changes, not as a stand-alone solution. A clinician may ask what approaches you have already tried, what made them difficult to sustain and whether practical barriers such as pain, shift work, caring responsibilities, finances or poor sleep need addressing.
You do not need to demonstrate extreme dieting or intensive exercise. Restrictive plans can be nutritionally inadequate and may be inappropriate for people with a history of disordered eating. The aim is usually to build sustainable habits, such as balanced meals, suitable portions, gradual activity and routines that support sleep and stress management.
Some treatments work by increasing fullness, reducing hunger or changing how the digestive system handles nutrients. These effects can make behavioural changes easier for some people, but responses vary. Follow-up is needed to assess tolerability, adherence and whether treatment is producing a clinically meaningful benefit within the timeframe specified for that medicine.
Who may not be suitable for prescription weight-loss medication?
Prescription treatment may be unsuitable during pregnancy or breastfeeding, for people below the medicine's age or BMI criteria, or when there is a relevant contraindication. Suitability can also be affected by severe kidney or liver disease, certain digestive or endocrine conditions, previous pancreatitis, eating disorders, mental health concerns or interactions with existing medicines.
Different medicines have different restrictions, so being unsuitable for one option does not necessarily exclude every form of support. A clinician might recommend lifestyle support, management of an underlying condition, referral to a specialist service or discussion with your GP. In some cases, further tests or stabilisation of another health problem are needed first.
Tell the prescriber if you have experienced binge eating, purging, severe food restriction or significant distress around food or body image. This should be handled sensitively and without judgement. Medication may not be the right first step, and specialist psychological or eating-disorder support may offer a safer and more appropriate route.
Children and teenagers require specialist assessment because they are still growing and adult BMI thresholds do not apply in the same way. Their BMI is interpreted using age- and sex-specific growth centiles. Family circumstances, physical health, emotional wellbeing, growth and development should all be considered before treatment is recommended.
Some prescription treatments have an authorised use for particular adolescent age groups under defined conditions, but they are not suitable for routine unsupervised use. Access and monitoring requirements differ from those for adults. Parents or carers should speak to the young person's GP, who can assess them and refer to a paediatric weight-management service if appropriate.
How can you access weight-loss treatment in the UK?
Your GP is a suitable first contact, particularly if you have unexplained weight change, multiple health conditions or symptoms such as excessive thirst, loud snoring or menstrual changes. They can review possible underlying causes, arrange tests and discuss local NHS weight-management services, dietetic support or specialist referral.
NHS access to prescription medication depends on national guidance, local pathways, service capacity and individual clinical criteria. Eligibility under a medicine's licence does not necessarily mean it will be available through every NHS service. Bariatric surgery has separate assessment and referral criteria and is generally considered after appropriate non-surgical management and multidisciplinary review.
A GPhC-registered online pharmacy may provide a private clinical assessment for eligible adults. The prescriber should confirm that treatment is appropriate, explain costs and monitoring, and communicate with your GP where clinically necessary and with appropriate consent. Avoid websites that offer prescription treatment without meaningful health checks or ongoing clinical support.
What happens after you start weight-loss treatment?
Follow-up should assess adverse effects, eating and drinking, changes in health, and whether the treatment remains appropriate. Some medicines are increased gradually over several weeks to improve tolerability. Dose changes should follow the prescriber's instructions rather than being accelerated to pursue quicker results, as this can increase the risk of side effects.
Continuation rules vary. Some treatments should be reviewed after a set period and stopped if a defined proportion of initial body weight has not been lost. A common licensed review point for certain options is 12 weeks on the full or maximum tolerated dose, but the exact rule depends on the medicine. Health improvements and tolerability are also relevant.
Seek urgent medical advice for severe or persistent abdominal pain, repeated vomiting, signs of dehydration, a serious allergic reaction or other concerning symptoms. Contact the prescriber promptly if your health changes, you start another medicine, or pregnancy occurs or is planned. Never share treatment or obtain extra doses from unregulated sellers.
Ask why the option is suitable for you, how it works, how it is taken and what monitoring is required. You should understand common side effects, rare but serious risks, interactions and what to do if you miss a dose. It is also reasonable to ask how treatment will fit around meals, work, travel and existing health care.
Discuss how long treatment may continue and what happens if it is ineffective, poorly tolerated or stopped. Appetite can increase after stopping some treatments, so a maintenance plan matters. A good service will set realistic expectations, provide behavioural support where possible and arrange review rather than treating prescribing as a one-off transaction.
Key takeaways
- BMI is a screening tool, and eligibility also depends on health risks, medical history and treatment safety.
- Some medicines may be considered from a BMI of 30 kg/m², or 27 kg/m² with a weight-related condition, but criteria vary.
- BMI assessment thresholds may be reduced by 2.5 kg/m² for some ethnic backgrounds because health risks can occur at lower BMI levels.
- Prescription medication is one option alongside nutrition, activity, sleep and behavioural support after clinical assessment.
- Pregnancy, breastfeeding, contraindications, interactions and some health conditions may make medication unsuitable.
- Eligibility under a medicine's licence does not guarantee access through a particular NHS or private service.
Frequently asked questions
Can I get weight-loss treatment if my BMI is under 30?
Possibly. Some prescription treatments may be considered from a BMI of 27 kg/m² if you have a qualifying weight-related condition. Lower assessment thresholds may apply to some ethnic backgrounds. The exact criteria differ by treatment, and a clinician must confirm that the expected benefits outweigh the risks.
Does type 2 diabetes make me eligible?
Type 2 diabetes is a relevant weight-related condition and may affect eligibility, but it does not automatically qualify you for treatment. Your BMI, glucose-lowering medicines, kidney function and risk of low blood sugar may need review. Your prescriber may coordinate care with your GP or diabetes team.
Can I use weight-loss medication while pregnant or breastfeeding?
Prescription weight-loss medication is generally not used during pregnancy or breastfeeding. Some treatments must also be stopped before trying to conceive, with the required interval depending on the medicine. Tell your prescriber immediately if you are pregnant, think you may be pregnant or plan to conceive.
Is BMI the only factor used to decide eligibility?
No. BMI helps estimate weight category but does not directly measure body fat or overall health. Clinicians also consider waist measurement, ethnicity, medical conditions, medicines, previous treatment, pregnancy status, eating-disorder history, personal preferences and whether safe monitoring can be provided.
Will I stay eligible if the treatment is not working?
Not always. Each medicine has review and stopping criteria. The prescriber may assess progress after a defined period at the full or highest tolerated dose and discontinue treatment if the required response is not achieved. Side effects, safety concerns or changes in your health may also require treatment to stop.
Where should I check whether treatment is suitable?
Speak to your GP, a specialist weight-management service or an appropriately regulated prescriber. Sphere Pharmacy can provide a clinical assessment for adults seeking private treatment, but prescribing is only considered after suitability checks. Seek GP advice if you have unexplained weight changes, complex conditions or concerning symptoms.
This article is for general information and is not personalised medical advice. Prescription weight-loss treatment is only available following a clinical assessment and is not suitable for everyone. Speak to your GP or a Sphere clinician before making changes to treatment.
Related articles
Oral Weight-Loss Treatment, Explained (Without the Hype)
How to Lose Weight Without the Gym
Weight and Health: Sorting Facts From Noise
How to Set Realistic Weight-Loss Goals (That You'll Actually Keep)
Do Weight-Loss Tablets Actually Work? What the Evidence Says